Association of insulin gene VNTR polymorphism with polycystic ovary syndrome

被引:42
作者
Vanková, M
Vrbíková, J
Hill, M
Cinek, O
Bendlová, B
机构
[1] Inst Endocrinol, Prague 11694 1, Czech Republic
[2] Charles Univ, Fac Med 2, Dept Pediat 2, Prague, Czech Republic
来源
LIPIDS AND INSULIN RESISTANCE: THE ROLE OF FATTY ACID METABOLISM AND FUEL PARTITIONING | 2002年 / 967卷
关键词
polycystic ovary syndrome; INSVNTR; genetic association;
D O I
10.1111/j.1749-6632.2002.tb04317.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Variability in the number of tandem repeats of the insulin gene (INS VNTR) is known to influence several phenotypes, including polycystic ovary syndrome (PCOS), diabetes mellitus type 1, diabetes mellitus type 2, and birth weight. The presence of the class III allele of INS VNTR has been reported to be protective in diabetes mellitus type 1, but in contrary it increases the disease risk of PCOS and diabetes mellitus type 2. PCOS is a very common endocrinopathy in women of reproductive age. The etiology of PCOS is uncertain, but family history of this syndrome suggests a major genetic cause. The aim of this pilot study was to investigate the possible association of INS VNTR polymorphism with PCOS in Czech women. In PCOS, significantly higher WHR, BMI, G(0), G(180), I-30, Cp-0, Cp-30, Cp-60, AUC-I, AUC-Cp, and insulinogenic index and significantly lower AUC-G/AUC-1 were found. No significant differences in INS VNTR genotype, phenotype, or allele frequencies were found between PCOS and controls. In spite of several differences in anthropometric and biochemical parameters (abdominal fat localization, increased P-cell function, and lower insulin sensitivity in PCOS women), no effect of INS VNTR polymorphism was found on insulin secretion, insulin action, or any other screened parameter.
引用
收藏
页码:558 / 565
页数:8
相关论文
共 24 条
[1]   THE HIGHLY POLYMORPHIC REGION NEAR THE HUMAN INSULIN GENE IS COMPOSED OF SIMPLE TANDEMLY REPEATING SEQUENCES [J].
BELL, GI ;
SELBY, MJ ;
RUTTER, WJ .
NATURE, 1982, 295 (5844) :31-35
[2]   INSULIN RELEASE AND PERIPHERAL SENSITIVITY AT THE ORAL GLUCOSE-TOLERANCE TEST [J].
CEDERHOLM, J ;
WIBELL, L .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1990, 10 (02) :167-175
[3]   POLYCYSTIC-OVARY-SYNDROME AND RISK FOR MYOCARDIAL-INFARCTION - EVALUATED FROM A RISK FACTOR MODEL BASED ON A PROSPECTIVE POPULATION STUDY OF WOMEN [J].
DAHLGREN, E ;
JANSON, PO ;
JOHANSSON, S ;
LAPIDUS, L ;
ODEN, A .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1992, 71 (08) :599-604
[4]  
Drivsholm T, 1999, DIABETOLOGIA, V42, pA185
[5]   Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis [J].
Dunaif, A .
ENDOCRINE REVIEWS, 1997, 18 (06) :774-800
[6]   A SIMPLE MEASURE OF INSULIN-RESISTANCE [J].
DUNCAN, MH ;
SINGH, BM ;
WISE, PH ;
CARTER, G ;
ALAGHBANDZADEH, J .
LANCET, 1995, 346 (8967) :120-121
[7]   Association of the INS VNTR with size at birth [J].
Dunger, DB ;
Ong, KKL ;
Huxtable, SJ ;
Sherriff, A ;
Woods, KA ;
Ahmed, ML ;
Golding, J ;
Pembrey, ME ;
Ring, S ;
Bennett, ST ;
Todd, JA .
NATURE GENETICS, 1998, 19 (01) :98-100
[8]  
Franks S, 1999, ANN ENDOCRINOL-PARIS, V60, P131
[9]   The genetic basis of polycystic ovary syndrome [J].
Franks, S ;
Gharani, N ;
Waterworth, D ;
Batty, S ;
White, D ;
Williamson, R ;
McCarthy, M .
HUMAN REPRODUCTION, 1997, 12 (12) :2641-2648
[10]   Current developments in the molecular genetics of the polycystic ovary syndrome [J].
Franks, S ;
Gharani, N ;
Waterworth, D ;
Batty, S ;
White, D ;
Williamson, R ;
McCarthy, M .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1998, 9 (02) :51-54